Zobrazeno 1 - 6
of 6
pro vyhledávání: '"David L. Meichenbaum"'
Autor:
Gloria K. Lee, Christopher Lopata, Marcus L. Thomeer, Jeffery D. Fox, David L. Meichenbaum, Alanna M. Lipinski, Rachael A. Smith, Martin A. Volker, Jennifer A. Toomey, Christin A. McDonald
Publikováno v:
Focus on Autism and Other Developmental Disabilities. 30:115-125
This community effectiveness trial examined the feasibility and efficacy of a comprehensive psychosocial treatment for 28 children, aged 7 to 10 years with high-functioning autism spectrum disorders (HFASDs). Treatment included instruction and therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fb8a3716b66939dbdbd94d6d9c71c64
https://doi.org/10.1177/1088357614525662
https://doi.org/10.1177/1088357614525662
Autor:
Andrea M. Chronis, David L. Meichenbaum, Andy Lopez-Williams, Donald A. Caserta, Elizabeth M. Gnagy, William E. Pelham, Adia N. Onyango, Gregory A. Fabiano, Michael J. Manos, Lisa Burrows-MacLean, Erika K. Coles, Sara Swain
Publikováno v:
Behavior Therapy. 35:449-469
Behavior modification is an evidence-based treatment for children with attentiondeficit/hyperactivity disorder (ADHD). Time-out from positive reinforcement is one behavior-modification procedure commonly recommended to manage disruptive or noncomplia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00b2bb4f61f301abff75b445e68d8f0a
https://doi.org/10.1016/s0005-7894(04)80027-3
https://doi.org/10.1016/s0005-7894(04)80027-3
Autor:
David L. Meichenbaum, Elizabeth M. Gnagy, Margaret H. Sibley, William E. Pelham, Bradley H. Smith, Oscar G. Bukstein
Publikováno v:
Journal of attention disorders. 21(2)
This study explored the nature of interactions between adolescent males with ADHD and their mothers, and the effects of methylphenidate (MPH) on an analogue parent–teen interaction task. Twenty-five adolescent males with ADHD ( M = 13.6 years) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63cbdab94590de1960b12fd889447aa7
https://pubmed.ncbi.nlm.nih.gov/23543401
https://pubmed.ncbi.nlm.nih.gov/23543401
Autor:
Andy Lopez-Williams, David L. Meichenbaum, Jerome J. Schentag, James G. Waxmonsky, Gregory A. Fabiano, Carlos J. Panahon, William E. Pelham, Elizabeth M. Gnagy, Martin T. Hoffman, Lisa Burrows-MacLean, Mario A. González, Gregory L. Forehand, Katy E. Tresco, Erika K. Coles, Charles H. Ballow
Publikováno v:
Journal of attention disorders. 15(1)
Objective: To test the efficacy and tolerability of the methylphenidate transdermal formulation (MTS) against immediate-release methylphenidate (IR MPH) and placebo in a 12-hr analog classroom setting. Method: A total of nine boys ages 6 to 9 years,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd90c88ec5ee47d15c2b4224624f4a95
https://pubmed.ncbi.nlm.nih.gov/20439487
https://pubmed.ncbi.nlm.nih.gov/20439487
Autor:
Randi L. Steiner, David L. Meichenbaum, William E. Pelham, Andrea M. Chronis, Adia N. Onyango, Elizabeth M. Gnagy, Lisa Burrows-MacLean, Helen R. Aronoff, Gregory A. Fabiano, Andrew Williams
Publikováno v:
Pediatrics. 104(6)
Objective. 1) To compare standard twice-daily methylphenidate (MPH) dosing with a single morning dose of MPH and of Adderall during a typical school-day time period, and 2) to conduct a dose-response study of the effects of a late-afternoon (3:30 pm)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e7029cc1913470bc611b9cda27def70
https://pubmed.ncbi.nlm.nih.gov/10585981
https://pubmed.ncbi.nlm.nih.gov/10585981
Autor:
Andrew Williams, Martin T. Hoffman, Carlos J. Panahon, Erika K. Coles, Andrea M. Chronis, Gregory A. Fabiano, Celeste A. Nguyen, Gene D. Morse, Gregory L. Forehand, Thomas M. Lock, David L. Meichenbaum, Karl Fielbelkorn, Lisa Burrows-MacLean, Elizabeth M. Gnagy, Randi L. Steiner, Adia N. Onyango, William E. Pelham, Sean M. Morrisey
Publikováno v:
Pediatrics. 107:e105-e105
Objective.Methylphenidate (MPH), the most commonly prescribed drug for attention-deficit/hyperactivity disorder (ADHD), has a short half-life, which necessitates multiple daily doses. The need for multiple doses produces problems with medication admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe982b518de05872bd7e08c3abef7024
https://doi.org/10.1542/peds.107.6.e105
https://doi.org/10.1542/peds.107.6.e105